CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study of Irinotecan, 5-Fluorouracil and Leucovorin for Treatment in Patients with Previously Untreated Advanced Colorectal Cancer
Sang-Byung Bae, Nam-Su Lee, Han-Jo Kim, Kyoung-Ha Kim, Hyun-Jung Kim, Chan-Kyu Kim, Kyu-Taeg Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park
Cancer Research and Treatment. 2006;38(2):72-77.   Published online 2006 April 30    DOI: https://doi.org/10.4143/crt.2006.38.2.72

Excel Download

A Phase II Study of Irinotecan, 5-Fluorouracil and Leucovorin for Treatment in Patients with Previously Untreated Advanced Colorectal Cancer
Cancer Research and Treatment. 2006;38(2):72   Crossref logo
Link1 Link2

Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer☆☆☆★Abstracted from: Douillard J, Hoff P, Skillings J et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2002; 20: 3605–16.
Cancer Treatment Reviews. 2003;29(1):59-63   Crossref logo
Link1 Link2

Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial
Yearbook of Oncology. 2008;2008:233-234   Crossref logo
Link1 Link2

6578 A randomized phase II study of irinotecan monotherapy versus irinotecan plus 5-fluorouracil/leucovorin combination as a salvage chemotherapy in previously treated patients with advanced/metastatic gastric cancer
European Journal of Cancer Supplements. 2009;7(2):383-384   Crossref logo
Link1 Link2

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
Annals of Oncology. 2001;12(11):1575-1580   Crossref logo
Link1 Link2 Link3

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
European Journal of Cancer. 2013;49(6):1236-1245   Crossref logo
Link1 Link2

A Ugt1a1*28 and *6 Genotype-Directed Phase I Study of Irinotecan Plus Infusional Leucovorin and 5-Fluorouracil (sLV5FU2) in Patients with Previously Untreated Metastatic Colorectal Cancer (MCRC)
Annals of Oncology. 2012;23:xi26-xi27   Crossref logo
Link1 Link2

A randomized Phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation
OncoTargets and Therapy. 2015;1061   Crossref logo
Link1

A Phase II Study of ANGIOZYME® in combination with 5-fluorouracil, leucovorin and ironotecan in the treatment of metastatic colorectal cancer patients
European Journal of Cancer. 2002;38:S72   Crossref logo
Link1 Link2

Irinotecan/5-Fluorouracil/Leucovorin in Advanced Colorectal Cancer: Oncologic Drugs Advisory Committee Summary
Clinical Colorectal Cancer. 2002;2(1):8-10   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.